Clinical Analysis of 107 NSCLC Patients Harboring KRAS Mutation

Clinical Analysis of 107 NSCLC Patients Harboring KRAS Mutation

Background and objective Kirsten rat sarcoma viral oncogene (KRAS) mutation is one of the major driver genes of non-small cell lung cancer (NSCLC). KRAS is a resistant predictor of epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs), which raises controversy because of its role i...

Full description

Bibliographic Details
Main Authors: Quan ZHANG, Jinghui WANG, Xi LI, Hui ZHANG, Jingying NONG, Na QIN, Xinyong ZHANG, Yuhua WU, Xinjie YANG, Jalin LV, Shucai ZHANG
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2016-05-01
Series:Chinese Journal of Lung Cancer
Subjects:
KRAS mutation
Lung neoplasms
First-line chemotherapy
Targeted therapy
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2016.05.02

Internet

http://dx.doi.org/10.3779/j.issn.1009-3419.2016.05.02

Similar Items